MORN

Morningstar, Inc.

$0.00

-6.46%
Jun 18, 2026
Bobby Quantitative Model
Morningstar, Inc. is a leading global provider of independent investment research, data, and analysis, operating in the Financial Services sector with a focus on financial data and stock exchanges. The company serves financial advisers, asset managers, and investors through its five key segments: Morningstar Direct Platform, PitchBook, Morningstar Credit, Morningstar Wealth, and Morningstar Retirement, with its flagship Direct Platform being the primary revenue driver. The current investor narrative centers on the company's strategic evolution from a traditional investment research firm into a diversified data and analytics platform, particularly through its PitchBook and Wealth Management segments, amidst a challenging environment for asset-based revenue streams and a significant stock price correction over the past year. Recent financial results and the stock's sharp decline are driving debate about the sustainability of its growth trajectory and the valuation impact of its ongoing business model transition.

People also watch

S&P Global

S&P Global

SPGI

Analysis
CME Group

CME Group

CME

Analysis
Intercontinental Exchange

Intercontinental Exchange

ICE

Analysis
Moody's Corporation

Moody's Corporation

MCO

Analysis
Nasdaq, Inc.

Nasdaq, Inc.

NDAQ

Analysis

MORN 12-Month Price Forecast

Historical Price
Current Price $153.68
Average Target $153.68
High Target $176.732
Low Target $130.62800000000001

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Morningstar, Inc.'s 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.

Average Target

$0.00

1 analysts

Implied Upside

vs. current price

Analyst Count

1

covering this stock

Price Range

$0 - $0

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Analyst coverage for Morningstar appears limited, with data indicating only one analyst providing estimates, resulting in insufficient breadth to establish a reliable consensus. The single analyst's revenue estimate for the period is approximately $2.993 billion, with EPS estimates clustering around $17.29. The lack of a broad analyst target price and recommendation distribution suggests limited institutional research coverage, which is atypical for a company of its market cap (~$9.1 billion) and may contribute to higher volatility and less efficient price discovery. The provided institutional ratings show a pattern of stable, bullish sentiment from the few firms that do cover the stock, with BMO Capital maintaining an 'Outperform' rating through multiple reiterations in 2025 and 2026, and UBS maintaining a 'Buy' rating as of October 2025. However, a notable shift occurred in October 2024 when Redburn Atlantic downgraded the stock from 'Buy' to 'Neutral', which may have preceded the stock's significant underperformance. The absence of a wide target price range from a consensus view means investor sentiment must be gauged from the price action and limited commentary, with the recent downgrade signaling some fundamental concerns that have yet to be fully resolved by the remaining bullish analysts.

Drowning in data?

Find the real signal!

MORN Technical Analysis

The prevailing price trend for Morningstar is a pronounced and sustained downtrend, characterized by a 1-year price change of -42.66%. The stock closed at $175.22, which is approximately 10.8% above its 52-week low of $149.08 but a substantial 44.7% below its 52-week high of $316.71; this positioning near the lower end of its annual range suggests the stock is in a deep correction phase, potentially offering a value opportunity if fundamentals stabilize, but also risks being a 'falling knife' if the downtrend persists. The stock's beta of 0.987 indicates its volatility is nearly identical to the broader market, yet its 1-year relative strength of -65.52% versus the SPY's +22.86% gain highlights severe and persistent underperformance. Recent short-term momentum shows a modest positive divergence, with the stock up 5.41% over the past month against a flat SPY (-0.08%). However, this nascent recovery is fragile, as the 3-month change remains negative at -4.36%, significantly underperforming the SPY's +12.0% gain, and the 6-month decline of -18.16% further confirms the bearish medium-term trend. This 1-month uptick against a sharply negative longer-term backdrop could signal either a temporary technical rebound or the early stages of a base formation, but the weak volume data (average of ~504k shares) suggests a lack of strong conviction behind the recent bounce. Key technical levels are clearly defined, with formidable resistance at the 52-week high of $316.71 and immediate support at the 52-week low of $149.08. A decisive break below the $149 support would likely trigger a new leg down, while a sustained move above the recent recovery high near $220 (seen in early January) is needed to suggest a trend reversal. The stock's maximum drawdown of -50.94% over the provided period underscores the severe downside volatility experienced, and with a beta near 1.0, this drawdown is largely idiosyncratic, pointing to company-specific concerns rather than broad market weakness as the primary driver.

Beta

0.99

0.99x market volatility

Max Drawdown

-51.0%

Largest decline past year

52-Week Range

$149-$317

Price range past year

Annual Return

-49.2%

Cumulative gain past year

PeriodMORN ReturnS&P 500
1m-10.6%+0.7%
3m-14.2%+15.1%
6m-28.7%+9.7%
1y-49.2%+25.0%
ytd-27.0%+9.5%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MORN Fundamental Analysis

Morningstar's revenue trajectory shows steady but decelerating growth; the most recent quarterly revenue (Q4 2025) was $641.1 million, representing a year-over-year growth of 8.48% from the $591.0 million reported in Q4 2024. However, examining the sequential quarterly revenue from Q1 2025 ($581.9M) to Q4 2025 ($641.1M) reveals a generally upward trend within the fiscal year, though the pace of growth appears to have moderated from the stronger year-over-year comparisons seen in prior periods. The revenue segment data indicates the business is heavily reliant on Licensed-Based revenue ($437.8M), which forms the core, with Asset-Based ($90.2M) and Transaction-Based ($113.1M) contributing smaller portions, suggesting investor focus on the stability of its subscription-like licensed revenue streams. The company is profitable, with Q4 2025 net income of $115.1 million and a trailing net margin of 15.30%. Gross margin remains healthy at 61.03% for the quarter, consistent with its software and data-driven business model. Operating margin for Q4 2025 was 21.53%, demonstrating solid operational efficiency. A review of recent quarters shows net income has been volatile but positive, with Q4 2025's $115.1M showing a slight decline from $116.9M in Q4 2024, while the net margin compressed from 19.78% to 17.95% year-over-year, indicating some pressure on profitability despite revenue growth. The balance sheet and cash flow position is mixed. The company generated strong free cash flow of $442.6 million on a trailing twelve-month basis, providing ample internal funding for operations and shareholder returns. However, the debt-to-equity ratio of 1.15 indicates a leveraged balance sheet, though the current ratio of 0.99 suggests potential tightness in short-term liquidity. Return on equity is robust at 30.62%, showcasing efficient use of shareholder capital. The substantial free cash flow yield, implied by the market cap and TTM FCF, supports financial flexibility, but the elevated debt level warrants monitoring, especially in a higher interest rate environment.

Quarterly Revenue

$641100000.0B

2025-12

Revenue YoY Growth

+0.08%

YoY Comparison

Gross Margin

+0.61%

Latest Quarter

Free Cash Flow

$442600000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Asset-Based
Licensed-Based
Transaction-Based

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MORN Overvalued?

Given Morningstar's positive net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio stands at 24.33x, while the forward P/E is significantly lower at 12.94x. This substantial gap implies the market is pricing in a sharp recovery in earnings, with forward estimates ($17.29 EPS) suggesting nearly a doubling from the most recent quarterly EPS (annualized run-rate of ~$11.36), reflecting high growth expectations embedded in the current price. Compared to industry averages, Morningstar's trailing P/E of 24.33x and Price-to-Sales (P/S) ratio of 3.72x are not directly comparable without a provided sector benchmark, but the P/S ratio of 3.7x is typical for a profitable, growing financial data company. The forward P/E of 12.9x appears reasonable if the company can deliver on its elevated earnings projections. The EV/EBITDA of 13.77x and EV/Sales of 3.23x provide additional context, suggesting the market values the company's cash flow and sales at a moderate multiple relative to its enterprise value. Historically, the stock's own valuation has compressed significantly. The historical ratios data shows the trailing P/E ratio has ranged from highs above 50x in early 2023 to the current 24.33x. The current P/E is below the levels seen throughout much of 2023 and 2024 (often above 30x), indicating the stock is trading at a discount to its own historical valuation range. This compression likely reflects the market's reassessment of growth prospects and the significant price decline, moving from a premium growth multiple towards a more normalized level. The current P/B ratio of 7.45, while high in absolute terms, is also below its historical peaks above 10x.

PE

24.3x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -284x~697x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

13.8x

Enterprise Value Multiple